Skip to main content

Sarns TCM and TCM II Cooling & Heating Systems Recalled

Sarns TCM and TCM II Cooling & Heating Systems Recalled

Sarns TCM and TCM II Cooling & Heating Systems Recalled

Introduction

The U.S. FDA announced a recall for Terumo’s Sarns TCM and TCM II Cooling and Heating Systems used for regulating patient body temperature during surgery. The FDA was prompted to take this decision after Terumo sent a letter to customers informing them about the new cleaning instructions after they found a potential for nontuberculous mycobacterium (NTM) to grow in the water tanks of the recalled units, which could be transferred to patients, resulting in infections and other adverse events, particularly for patients undergoing cardiovascular surgery.

The Terumo products recalled by FDA are Sarns TCM (Temperature Control and Monitor Unit) and TCM II Cooling and Heating Systems, and HX2 Temperature Management Systems. The infection is similar to the one caused by Sorin 3T Heating and Cooling System. Around 450 Sarns Devices may be affected by the recall.

Stockert 3T Heater-Cooler Systems manufactured by LivaNova PLC (formerly Sorin Group Deutschland GmbH), extensively used in heart surgeries across the U.S. to regulate the patient body temperature, has also been linked to NTM infections.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!